GENEOS Therapeutics, Inc.
Biotechnology company · Plymouth Meeting, Pennsylvania, United States
GENEOS Therapeutics, Inc. is a biotechnology company headquartered in Plymouth Meeting, Pennsylvania, United States. Its earliest recorded incorporation is in 2016. It has reported private securities offerings to the US SEC, most recently $5 million sold in a notice filed in 2023.
GENEOS Therapeutics at a glance
What does GENEOS Therapeutics do?
Private fundraising reported to the SEC
4 Form D notices; the most recent reported $5 million sold (2023).
Frequently asked questions about GENEOS Therapeutics
Where is GENEOS Therapeutics headquartered?
GENEOS Therapeutics, Inc. is headquartered in Plymouth Meeting, Pennsylvania, United States.
What does GENEOS Therapeutics do?
GENEOS Therapeutics, Inc. is a biotechnology company.
When was GENEOS Therapeutics founded?
The earliest incorporation on record for GENEOS Therapeutics, Inc. is in 2016, according to public company registers.
Similar companies
- Genaera CorpPlymouth Meeting, Pennsylvania, United States
- Recursion PharmaceuticalsSalt Lake City, Utah, United States
- Vericel CorpBurlington, Massachusetts, United States
- SAB Biotherapeutics, Inc.Miami Beach, Florida, United States
- Adaptive Biotechnologies CorpSeattle, Washington, United States
- Inhibikase Therapeutics, Inc.Wilmington, Delaware, United States
- Cognition Therapeutics IncPurchase, New York, United States
- Agenus IncLexington, Massachusetts, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-23. Data licences